Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.09
-1.22 (-7.97%)
Dec 12, 2025, 4:00 PM EST - Market closed
Crescent Biopharma Employees
Crescent Biopharma had 6 employees as of December 31, 2024.
Employees
6
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$11,911,333
Market Cap
275.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CBIO News
- 11 days ago - Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors - GlobeNewsWire
- 11 days ago - Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics - GlobeNewsWire
- 27 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 5 weeks ago - Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Crescent Biopharma to Present at November Investor Conferences - GlobeNewsWire
- 5 weeks ago - Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting - GlobeNewsWire
- 3 months ago - Crescent Biopharma to Present at September Investor Conferences - GlobeNewsWire
- 4 months ago - Crescent Biopharma: Chasing The Summit Hype - Seeking Alpha